Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03593486 · ClinicalTrials.gov registry record · NA

Low-Level EMF Stimulation for Paroxysmal Atrial Fibrillation

A NA study, sponsored by University of Oklahoma.

Completed
Registry status
NA
Development phase
18
Enrollment target

NCT03593486 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 18 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03593486, a NA study, has completed, sponsored by University of Oklahoma.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target

Study Summary

This research has two main specific aims. First, a commercially-available stimulator will be utilized to assess the effect of low-level electromagnetic field (EMF) stimulation on atrial fibrillation (AF) inducibility in patients with paroxysmal AF presenting for catheter ablation as compared to sham stimulation. We hypothesize a reduction in AF inducibility in patients treated with EMF stimulation. Second, we aim to assess for the effect of low-level EMF on level of systemic inflammatory mediators. We hypothesize a reduction in the level of the inflammatory mediator tissue necrosis factor (TNF)-α in patients treated with EMF stimulation as compared to sham stimulation. The long-term objective of this research is to develop low-level EMF as a therapeutic alternative for patients with AF, and this research will help to determine the efficacy of low-level pulsed EMF in this regard.

Interventions

  • DEVICE Sham Stimulation
  • DEVICE Low-level Pulsed EMF

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2018-09-27
Est. Completion 2019-11-26
Phase NA

Sponsor

University of Oklahoma

358 total trials

What the Registry Record Tells You About NCT03593486

The ClinicalTrials.gov registry entry for NCT03593486 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Sham Stimulation is the first listed.

NCT03593486 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03593486 about?

NCT03593486 is a clinical study titled "Low-Level EMF Stimulation for Paroxysmal Atrial Fibrillation". This research has two main specific aims. First, a commercially-available stimulator will be utilized to assess the effect of low-level electromagnetic field (EMF) stimulation on atrial fibrillation (AF) inducibility in patients with paroxysmal AF presenting for catheter ablation as compared to sham...

What is the current status of trial NCT03593486?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2018-09-27. Estimated completion is 2019-11-26.

What interventions are being tested in trial NCT03593486?

The interventions under investigation include: Sham Stimulation (DEVICE), Low-level Pulsed EMF (DEVICE).

Who is sponsoring clinical trial NCT03593486?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.